Introduction
============

Neuronal ceroid lipofuscinoses (NCLs) are autosomal recessive disorders that lead to progressive neurodegeneration and early death in humans ([@bib36]; [@bib31]; [@bib53]). NCLs are typified by the accumulation of autofluorescent material in the lysosome followed by subsequent neuron loss and result from mutations in genes encoding lysosomal enzymes or transmembrane domain (TMD)--containing proteins of unknown function possibly connected to protein palmitoylation ([@bib46]; [@bib31]; [@bib53]; [@bib49]; [@bib18]). For example, *CLN1*, which is involved in infantile NCL, encodes a palmitoyl protein thioesterase ([@bib57]; [@bib31]). More recently, *CLN3*, which is involved in juvenile-onset NCL or Batten disease, was suggested to encode a palmitoyl protein Δ-9 desaturase predicted to convert palmitoylated protein substrates into palmitoylated derivatives ([@bib37]; [@bib49]). How defects in these genes lead to neurodegeneration is unknown, and the connection between NCL-related proteins, protein palmitoylation, and identity of the palmitoylated substrates is obscure.

Some genes associated with NCLs are conserved. The best example is *CLN3*, which has a yeast orthologue called *BTN1* (see [Table S9](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp1} for name description; [@bib42]; [@bib14]). The deletion of *BTN1* in *Saccharomyces cerevisiae* yields defects in vacuolar pH homeostasis, amino acid uptake to the vacuole, vacuolar-type H^+^--ATPase (V-ATPase)--dependent H^+^ transport, and nitric oxide signaling and leads to the up-regulation of *BTN2*, a gene possibly involved in cellular adaptation to the loss of *BTN1* ([@bib45]; [@bib10]; [@bib9]; [@bib41]; [@bib40]). Although Btn1 is proposed to localize to and act at the level of the vacuole ([@bib14]; [@bib43], [@bib44]; [@bib45]; [@bib17]; [@bib28]; [@bib62]), many of these studies used gene overexpression, which often results in protein mislocalization. Recent studies suggest that Btn1 might localize to the Golgi in *S. cerevisiae* ([@bib58]) and *Schizosaccharomyces pombe* ([@bib12]).

We previously demonstrated that Btn2, which has similarity to the Hook family of coiled-coil proteins associated with endosomal processes ([@bib29]; [@bib56]; [@bib59]; [@bib50]), localizes to late endosomes (LEs) and mediates the retrieval of specific cargo proteins from LEs to the Golgi ([@bib26]). Btn2 binds to components involved in LE--Golgi protein retrieval, such as elements of the retromer complex (e.g., Vps26) and the Snc1/2 exo/endocytic vesicle SNAREs. Moreover, it forms a complex between a retrieved cargo protein (e.g., Yif1), the endocytic SNARE complex (e.g., Snc1/2, Vti1, Tlg1, and Tlg2), retromer (e.g., Vps5, 17, 26, 29, and 35), and a sorting nexin (e.g., Snx4; [@bib26]). This complex is specific to a subset of LE--Golgi-retrieved proteins because Vps10, the carboxypeptidase Y (CPY) receptor, cannot be coprecipitated with Btn2 and is not mislocalized in *btn2Δ* cells. This contrasts to mutants defective in retromer, Snx4, or Ypt6 (a Rab involved in LE--Golgi transport) that mislocalize both Vps10 and CPY. Thus, multiple routes may be involved in LE--Golgi protein retrieval, and Btn2 may be specific to one ([@bib26]). Interestingly, Btn2 also facilitates prion curing, indicating a potential role in the targeting of misfolded protein aggregates for degradation ([@bib30]). Recently, we demonstrated that Btn2 can localize to the insoluble protein deposit compartment ([@bib2]; [@bib25]) thought to be involved in prion sequestration and identified Btn3 as a negative regulator of Btn2-mediated LE--Golgi transport and prion curing ([@bib27]).

Given the connection between Btn2 and LE--Golgi transport, we examined whether Btn1 acts upon protein retrieval. We find that *BTN1* encodes a Golgi protein involved in the regulation of SNARE phosphorylation and assembly and controls LE--Golgi and intra-Golgi protein sorting. The deletion of *BTN1* phenocopies the loss of *BTN2*, resulting in the mislocalization of Yif1 and Kex2, and can be complemented by the heterologous expression of human *CLN3*. This suggests that the biochemical function of Btn1/Cln3 is conserved. Specifically, *BTN1* overexpression or deletion has opposing effects upon SNARE assembly and Golgi morphology, which are mediated through Sed5, a SNARE whose control of retrograde protein trafficking and Golgi morphology is sensitive to phosphorylation ([@bib61]). Btn1 appears to regulate the phosphorylation of Sed5 via Yck3, a palmitoylated kinase involved in Golgi--vacuole transport ([@bib55]) and whose deletion phenocopies *btn1Δ* or *btn2Δ* cells. The ability of Btn1 to regulate kinase function may involve modulation of the palmitate lipid anchor, as substitution of the cysteine acceptor region in Yck3 with a TMD suppresses the loss of *BTN1*. Thus, Btn1 controls a membrane-anchored kinase that functions in Golgi--endosome transport.

Results
=======

The deletion of *BTN1* results in the mislocalization of Yif1 and Kex2
----------------------------------------------------------------------

The loss of *BTN2* results in the mislocalization of a trans-Golgi protein, Yif1, to the vacuole ([@bib11]; [@bib26]), where it is degraded ([@bib26]). As *BTN2* is up-regulated in the absence of *BTN1* and because Btn2 acts upon LE--Golgi sorting, we determined whether Btn1 is involved in transport. We examined the localization of GFP-tagged Yif1 in wild-type (WT) cells or cells lacking either *BTN1* or *BTN2* ([Fig. 1 A](#fig1){ref-type="fig"}). In WT cells, GFP-Yif1 labeled small punctate structures that correspond to Golgi ([@bib34]) and did not colabel with FM4-64 ([Fig. 1 A](#fig1){ref-type="fig"} and [Table S1](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp2}), a dye that labels endosomes and then vacuoles. In contrast, GFP-Yif1 mislocalized to vacuoles in *btn2Δ* cells, as previously shown ([@bib11]; [@bib26]), and to FM4-64--labeled compartments situated adjacent to the vacuole (along with limited vacuolar labeling) in *btn1Δ* cells ([Fig. 1 A](#fig1){ref-type="fig"} and Table S1). The nonvacuolar compartments labeled by GFP-Yif1 in *btn1Δ* cells are likely to be LEs, as they colabeled with RFP-tagged Vps27 ([Fig. 1 B](#fig1){ref-type="fig"}), a protein involved in the multivesicular body (MVB) pathway ([@bib47]). Thus, the deletion of *BTN1* affects Yif1 localization in a manner similar to the deletion of *BTN2*. Importantly, Yif1 localization to the Golgi was almost fully restored to *btn1Δ* cells by expression of the human *CLN3* gene ([Fig. 1 A](#fig1){ref-type="fig"} \[bottom\] and Table S1). Thus, the function of these orthologues may be conserved.

![**The deletion of *BTN1* results in defects in LE--Golgi sorting.** (A) Yif1 is mislocalized to LEs in cells lacking *BTN1*. (top) WT (BY4741), *btn1Δ*, and *btn2Δ* cells expressing GFP-Yif1 from a single-copy plasmid were labeled with FM4-64 and visualized, as described in Materials and methods. Merge indicates merger of the GFP and FM4-64 (i.e., RFP) panels. Light indicates the DIC panel. The third row illustrates endosomal labeling seen with Yif1 in the majority of *btn1Δ* cells, whereas the fourth row illustrates vacuolar labeling. (bottom) *btn1Δ* cells expressing GFP-Yif1 from a single-copy plasmid and Cln3 from a multicopy plasmid; cells were labeled as previously described. (B) Yif1 localizes to Vps27-labeled endosomes in *btn1Δ* cells. WT and *btn1Δ* cells expressing GFP-Yif1 from a single-copy plasmid and RFP-Vps27 from a multicopy plasmid are shown. (C) Kex2 is mislocalized to LEs in cells lacking *BTN1*. (top) WT, *btn1Δ*, and *btn2Δ* cells expressing Kex2-GFP from a single-copy plasmid are shown. (bottom) *btn1Δ* cells expressing Kex2-GFP from a single-copy plasmid and Cln3 from a multicopy plasmid are shown. Bars, 1 µm.](JCB_201102115_RGB_Fig1){#fig1}

Next, we examined whether GFP-tagged Kex2, a protease retrieved to the trans-Golgi via LEs in WT cells ([@bib5]), is mislocalized in *btn1Δ* cells ([Fig. 1 C](#fig1){ref-type="fig"}). Kex2 accumulates at LEs in *btn2Δ* cells, and its mislocalization results in a loss in the secretion of active α-mating factor ([@bib27]). We found that Kex2-GFP accumulates in large LE-like structures that label with FM4-64 and are situated adjacent to the vacuole in both *btn1Δ* and *btn2Δ* cells ([Fig. 1 C](#fig1){ref-type="fig"} and [Table S2](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp3}). This indicates that Kex2 is not efficiently retrieved to the Golgi in the absence of either Btn1 or Btn2. Interestingly, Kex2 also relocalized to the Golgi when the *CLN3* was overexpressed in *btn1Δ* cells ([Fig. 1 C](#fig1){ref-type="fig"} and Table S2). Together, these results suggest that both Btn1 and Btn2 act upon LE--Golgi protein sorting.

To show specificity, we examined the localization of other proteins that undergo sorting on the secretory pathway in cells lacking *BTN1* ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp4}). These proteins (see Table S9) included GFP-tagged Snx4 ([@bib21]), Vps27, Vps10 ([@bib15]), Tlg1 ([@bib13]), Tlg2 ([@bib1]; [@bib22]), Snc1 ([@bib48]; [@bib19]), Fur4 ([@bib6]), Ste2 ([@bib54]), and CPY. However, we did not observe significant changes in their localization when expressed (from single-copy plasmids) in *btn1Δ* cells in comparison with WT cells (Fig. S1 A). This result was identical to that observed for *btn2Δ* cells ([@bib26]). We also examined CPY secretion, which occurs as a result of defects in vacuolar protein sorting. Although CPY was detected on filters where cells lacking *VPS10* or *VPS26* (which encode retromer components; [@bib52]) were grown, it was not detected where either WT or *btn1Δ* cells were grown (Fig. S1 B). Thus, in contrast to Yif1 or Kex2, neither CPY sorting nor the localization of other trafficked markers was altered in the absence of *BTN1*.

To verify the imaging data, we examined properties of these proteins that might support the idea that Yif1 and Kex2 are mislocalized. First, we examined the stability of GFP-Yif1 by Western analysis (Fig. S1 C), as the robust accumulation of free GFP was observed in cells lacking *BTN2* but not in WT cells ([@bib26]). Upon quantification, we found that the level of free GFP in *btn1Δ* cells was twofold that of WT cells but only half as much as that seen in control *btn2Δ* cells (unpublished data). Thus, Yif1 does not undergo the same level of degradation in *btn1Δ* cells as in *btn2Δ* cells, but this result parallels the microscopy data showing that 16% of *btn1Δ* cells have vacuolar labeling, whereas WT and control *btn2Δ* cells show 7 and 32% vacuolar labeling, respectively (Table S1). Next, we examined Kex2 function in α-factor maturation by scoring halo formation on lawns of *sst2Δ* tester cells. We found that the halo size (i.e., which delimits the area of mature and active secreted α-factor) was significantly reduced in the presence of either *btn1Δ* cells or *btn2Δ* cells in contrast to WT cells (e.g., the halo diameter was 7.5 mm for the spotted *btn1Δ* and *btn2Δ* cells vs. 10 mm for WT cells; *n* = 2; Fig. S1 D). Thus, Kex2 function is reduced in *btn1Δ* cells, suggesting that it localizes to a compartment that is unable to access immature α-factor.

Btn1 localizes to the Golgi and is retrieved from LEs in a Btn2-dependent manner
--------------------------------------------------------------------------------

The intracellular localization of Btn1 is unclear; GFP-tagged Btn1 localizes to the vacuole upon overexpression (i.e., from multicopy plasmids; [@bib14]; [@bib43], [@bib44]; [@bib45]; [@bib17]; [@bib28]) or to the Golgi in *S. cerevisiae* ([@bib58]) and *S. pombe* ([@bib12]) at lower levels of expression. We examined the localization of Btn1 tagged at the amino terminus with GFP to avoid masking a potential ER export sequence present at the carboxy terminus (position 353--357; LNILE) and expressed it from the genome or single-copy plasmids. GFP-Btn1 expressed from the chromosome under a *GAL* promoter, constitutively from a single-copy plasmid via an *ADH1* promoter, or endogenously under its own promoter localized to numerous small punctate structures that did not colocalize with FM4-64 ([Fig. 2 A](#fig2){ref-type="fig"}, top, middle, and bottom rows, respectively). These structures are likely to be trans-Golgi, as GFP-Btn1 colocalized with either RFP-tagged Yif1 or Sec7 ([Fig. 2 B](#fig2){ref-type="fig"}), which are both trans-Golgi markers. In contrast, GFP-Btn1 did not overlap with Btn2-RFP ([Fig. 2 C](#fig2){ref-type="fig"}), which localizes to LEs ([@bib26]). Thus, in contrast to experiments that show Btn1 to be vacuolar, we observe Btn1 as a Golgi protein. Moreover, GFP-Btn1 localization to the Golgi appears to be mediated by LE--Golgi protein retrieval, as GFP-Btn1 was mislocalized to the vacuole in cells lacking *BTN2* ([Fig. 2 D](#fig2){ref-type="fig"}), as with Yif1 or Kex2 ([Fig. 1, A and C](#fig1){ref-type="fig"}). However, we note that *GFP-BTN1* overexpression from multicopy plasmids indeed leads to labeling of the vacuole membrane (unpublished data).

![**Btn1 localizes to the Golgi in a manner dependent on Btn2.** (A) Btn1 does not colocalize with FM4-64--labeled compartments. (top) WT cells expressing *GFP*-tagged *BTN1* from its genomic locus under the control of a *GAL* promoter (*GAL* integrated \[*GAL* int\]) were grown on galactose-containing medium and were labeled with FM4-64. (middle) WT cells expressing *GFP-BTN1* constitutively from a single-copy plasmid (*CEN* plasmid) were grown on glucose-containing medium and were labeled with FM4-64. (bottom) WT cells expressing *GFP-BTN1* from its genomic locus and under the control of the *BTN1* promoter were grown on glucose-containing medium and were labeled with FM4-64. (B) Btn1 colocalizes with Yif1. WT cells expressing *GFP*-*BTN1* from its genomic locus under the control of a *GAL* promoter and either *RFP-YIF1* from a single-copy plasmid (top row) or *SEC7-DsRed* from a chromosomal integration (bottom row) were grown on galactose-containing medium and visualized. (C) Btn1 and Btn2 do not colocalize. WT cells expressing *GFP-BTN1* from its chromosomal locus under the control of a *GAL* promoter and *BTN2-RFP* from a single-copy plasmid are shown; cells were grown on galactose-containing medium. (D) Btn1 is mislocalized to the vacuole in *btn2Δ* cells. *btn2Δ* cells expressing *GFP-BTN1* from a single-copy plasmid were grown on glucose-containing medium and were labeled with FM4-64. Bars, 1 µm.](JCB_201102115_RGB_Fig2){#fig2}

*BTN1* overexpression or deletion affects the growth of SNARE mutants
---------------------------------------------------------------------

Previously, we demonstrated that *BTN2* overexpression ameliorates the growth of *vti1-11* cells ([@bib26]; [@bib27]), which are defective in Golgi to LE/MVB transport at elevated temperatures ([@bib16]). We examined the effect of *BTN1* overexpression or deletion in mutants of the secretory pathway and found that overexpression inhibited the growth of cells bearing temperature-sensitive alleles of *VTI1*, *YKT6*, and *SED5* ([Fig. S2, A--C](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp5}), which encode SNAREs involved in endosome--Golgi and intra-Golgi protein sorting. This is specific, as *BTN1* overexpression had little to no effect on the growth of cells bearing a temperature-sensitive allele of *SEC21*, which encodes a COPI component involved in retrograde Golgi--ER transport; *SEC22*, which encodes an ER--Golgi SNARE; and either *SEC1* or *SEC9*, which encode an exocytic SNARE regulator and SNARE, respectively (Fig. S2 D). Thus, the deleterious effects of *BTN1* overexpression are limited to cells that bear mutations in genes involved in endosome--Golgi and intra-Golgi transport. Correspondingly, the deletion of *BTN1* ameliorated growth defects seen in *ykt6-1* cells at elevated temperatures (Fig. S2 B). No effect by either the overexpression or deletion of *BTN1* was observed in WT cells (Fig. S2 E).

*BTN1* overexpression and deletion affect the assembly of Golgi SNAREs
----------------------------------------------------------------------

As Btn1 overproduction impedes the functioning of SNAREs specific to Golgi transport steps (e.g., Ykt6 and Sed5; Fig. S2), we examined SNARE assembly in cells either overexpressing or lacking *BTN1*. First, we immunoprecipitated an myc epitope--tagged temperature-sensitive form of Ykt6 (e.g., Ykt6-1; see Materials and methods) from WT and either *BTN1*-overexpressing or *btn1Δ* cells. In WT cells grown at permissive temperatures, we found that Ykt6-1 readily formed complexes with Sed5 and other SNAREs involved in ER--Golgi transport (e.g., Bet1 and Bos1), intra-Golgi transport (e.g., Sft1 and Gos1), and endosome--Golgi transport (e.g., Tlg1, Tlg2, and Vti1) but not with Sso1/2 or Snc1/2, which act primarily upon exocytosis ([Fig. 3 A](#fig3){ref-type="fig"}). In contrast, *BTN1* overexpression greatly reduced Ykt6-1 binding to Sed5 as well as to Vti1 and Tlg1 ([Fig. 3 A](#fig3){ref-type="fig"}). This indicates that SNARE partners involved in endosome--Golgi transport were less able to form complexes with Ykt6 upon *BTN1* up-regulation.

![**Overexpression or deletion of *BTN1* has opposing effects on Golgi SNARE assembly.** (A) *BTN1* overexpression or deletion affects SNARE partnering with Ykt6. WT and *btn1Δ* cells expressing myc-tagged Ykt6-1 from a single-copy plasmid and WT cells expressing both myc-tagged Ykt6-1 from a single-copy plasmid and HA-tagged Btn1 from a multicopy plasmid were processed for IP with anti-myc antibodies. Samples of the TCL were separated by SDS-PAGE in parallel to the IP samples. Proteins were detected using antibodies to SNAREs as well as the HA and myc epitopes to detect Btn1 and Ykt6-1, respectively. Note that Ykt6 did not precipitate Sso, Snc, or Btn1. (B) *BTN1* overexpression or deletion affects SNARE partnering with Sed5. Control WT and *btn1Δ* cells expressing HA-Sed5 from a single-copy plasmid and WT cells overexpressing myc-Btn1 from a multicopy plasmid were grown and processed for IP. Samples of the TCL and the IP precipitates were electrophoresed and detected in Western blots, as previously described. Note that Sed5 did not precipitate Tlg2, Sso1/2, or Btn1.](JCB_201102115_GS_Fig3){#fig3}

As Sed5 is an essential SNARE involved in Golgi transport ([@bib3]) and whose binding to Ykt6 was influenced by Btn1 ([Fig. 3 A](#fig3){ref-type="fig"}), we examined the effect of *BTN1* overexpression or deletion on the ability of Sed5 to assemble into SNARE complexes. We immunoprecipitated an HA-tagged form of Sed5 from WT and either *BTN1*-overexpressing or *btn1Δ* cells. In WT cells, Sed5 bound weakly to the Vti1 and Tlg1 endosome--Golgi transport SNAREs, the Ykt6, Gos1, and Sft1 intra-Golgi transport SNAREs, and the Bos1 ER--Golgi SNARE ([Fig. 3 B](#fig3){ref-type="fig"}). In contrast, *BTN1* overexpression greatly reduced, if not eliminated, SNARE binding to Sed5, whereas, correspondingly, the deletion of *BTN1* greatly enhanced binding ([Fig. 3 B](#fig3){ref-type="fig"}). This result is specific to Vti1, Tlg1, Ykt6, Gos1, Sft1, and Bos1, as Sed5 did not bind to the Tlg2, Sso1/2, or Snc1/2 SNAREs under any condition. Thus, the levels of Btn1 appear to control Sed5 assembly into specific SNARE complexes.

*BTN1* overexpression or deletion modulates Golgi clustering
------------------------------------------------------------

Previous work revealed that Sed5 undergoes phosphorylation at serine 317, which is adjacent to the TMD ([@bib61]). A constitutive nonphosphorylated (NP) form of Sed5 (e.g., Sed5^317A^) conferred normal Golgi function in terms of protein export and retrograde sorting events and readily entered into COPI vesicles but greatly enhanced Golgi clustering ([@bib61]). In contrast, a phosphomimicking mutant (e.g., Sed5^317D^) inhibited retrograde protein trafficking within the Golgi (i.e., leading to Kar2 secretion, defects in Gas1 processing, and Sec22 mislocalization) and cell growth and induced Golgi vesiculation ([@bib61]). Because Sed5 phosphorylation regulates Golgi morphology and function, we examined whether *BTN1* overexpression or deletion has similar effects.

First, we examined the effect of *BTN1* overexpression or deletion in WT cells expressing GFP-tagged Sed5, Sed5^317A^, or Sed5^317D^ from single-copy plasmids ([Fig. 4](#fig4){ref-type="fig"}; see [Table S3](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp6} for the percentage of cells having Sed5 in dispersed/clustered Golgi). In cells expressing GFP-tagged Sed5, which yielded numerous variably sized puncta ([Fig. 4 A](#fig4){ref-type="fig"}, top row; [@bib61]), we observed that the deletion of *BTN1* led to an enhancement of their size (i.e., increased clustering; [Fig. 4 A](#fig4){ref-type="fig"}, bottom row). In cells expressing Sed5^317A^ ([Fig. 4 B](#fig4){ref-type="fig"}, top row), which were previously shown to have greatly enlarged Golgi puncta ([@bib61]), the deletion of *BTN1* yielded even larger (although typically fewer) puncta (i.e., superclustering; [Fig. 4 B](#fig4){ref-type="fig"}, bottom row). Similar results were observed in *btn1Δ* cells expressing Sed5^317D^ ([Fig. 4 C](#fig4){ref-type="fig"}, bottom row), although these puncta were smaller than in the other cells lacking *BTN1* ([Fig. 4, A and B](#fig4){ref-type="fig"} \[bottom rows\]), probably as a result of the enhanced vesiculation exerted by Sed5^317D^ ([@bib61]). Conversely, *BTN1* overexpression led to smaller and more dispersed puncta in all cell types ([Fig. 4, A--C](#fig4){ref-type="fig"} \[middle rows\]). Thus, Btn1 levels greatly modulate Golgi clustering. The notable changes in size and number of Golgi puncta likely result from an effect that Btn1 has upon native Sed5 that is present in the WT background (and expressed from the plasmid in [Fig. 4 A](#fig4){ref-type="fig"}).

![***BTN1* overexpression or deletion has opposing effects on Golgi morphology.** (A) Deletion of *BTN1* enhances Golgi clustering in cells expressing GFP-Sed5. WT, *btn1Δ*, and WT cells overexpressing *BTN1* from a multicopy plasmid (*BTN1*) and all expressing GFP-Sed5 from a single-copy plasmid are shown. Note the large puncta in *btn1Δ* cells. (B) Deletion of *BTN1* enhances Golgi clustering in cells expressing GFP-Sed5^317A^, whereas *BTN1* overexpression enhances fragmentation (same as in A, except all strains express GFP-Sed5^317A^). Note the large puncta in WT and *btn1Δ* cells. (C) Golgi clustering is reduced in *btn1Δ* cells expressing GFP-Sed5^317D^ (same as in A*,* except all strains express GFP-Sed5^317D^). (D) Deletion of *BTN1* enhances Golgi clustering in cells expressing GFP-Sed5 from its genomic locus (GFP-Sed5 integrated \[int.\]). WT, *btn1Δ*, and WT cells overexpressing *BTN1* from a multicopy plasmid (*BTN1*) and all expressing *GFP-SED5* from its genomic locus are shown. Note the larger puncta in *btn1Δ* cells. (E) *BTN1* overexpression reduces Golgi clustering in cells expressing GFP-Sed5^317A^ from its genomic locus (same as in D, except all cells express *GFP-SED5^317A^*). Note the reduction in puncta size in cells overproducing Btn1. (F) Deletion of *BTN1* enhances Golgi clustering in cells expressing GFP-Sed5^317D^ from its genomic locus (same as in D, except all cells express *GFP-SED5^317D^*). Note the enhancement in puncta size in cells lacking *BTN1*. Bars, 1 µm.](JCB_201102115_RGB_Fig4){#fig4}

Second, we examined the effect of *BTN1* overexpression or deletion in WT cells expressing GFP-tagged Sed5, Sed5^317A^, or Sed5^317D^ from their genomic loci (i.e., as the sole copy of *SED5*; [Fig. 4, D--F](#fig4){ref-type="fig"}). We observed similar results as those seen with the plasmid-expressed forms of Sed5 ([Fig. 4, A--C](#fig4){ref-type="fig"}), although we note that the size of the Golgi clusters formed in the presence of Sed5^317A^ ([Fig. 4 E](#fig4){ref-type="fig"}) and/or in the absence of *BTN1* ([Fig. 4, D--F](#fig4){ref-type="fig"} \[bottom rows\]) was not as dramatic as that observed with plasmid-based *SED5* overexpression ([Fig. 4, A--C](#fig4){ref-type="fig"}). This connection between *SED5* expression levels and Golgi size was previously observed ([@bib61]).

Btn1 regulates the phosphorylation state of Sed5
------------------------------------------------

Because the deletion of *BTN1* enhances Golgi size ([Fig. 4](#fig4){ref-type="fig"}), which corresponds to the NP form of Sed5 ([@bib61]), and *BTN1* overexpression has an opposite effect that corresponds with phosphorylated (P) Sed5 ([@bib61]), we examined Sed5 phosphorylation in cells lacking or overexpressing *BTN1* by Western blotting with anti-Sed5 antibodies. Cell extracts from WT, *BTN1*-overexpressing, and *btn1Δ* cells were resolved on 11.5% acrylamide gels and were probed with anti-Sed5 antibodies to reveal the lower (NP) and higher (P) molecular mass forms ([@bib61]). As previously seen, Sed5 can exist in the P form in WT cells ([@bib61]), and this signal appeared somewhat stronger (≥15%) in WT cells overexpressing *BTN1* than in WT cells (see representative experiment shown in [Fig. 5 A](#fig5){ref-type="fig"}, top and bottom left). More strikingly, the P form of Sed5 was greatly reduced in *btn1Δ* cells, and quantification revealed that its levels were three- to fourfold lower than in WT cells after normalization for loading ([Fig. 5 A](#fig5){ref-type="fig"}, bottom left), although a small reduction in the levels of Sed5 protein was also apparent. The NP/P ratio for Sed5 in WT cells, WT cells overexpressing *BTN1*, and *btn1Δ* cells was 2.7:1, 2.2:1, and 5:1 in this representative experiment (NP/P ratio for *btn1Δ* cells was 7.2 ± 1.7:1 in four experiments; see [Figs. 6 (C and F)](#fig6){ref-type="fig"} and [S5 A](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp7} for similar results). Thus, excess Btn1 appears to enhance Sed5 phosphorylation, whereas its absence greatly enhances the NP state. These results could account for the changes in the aforementioned Golgi morphology observed ([Fig. 4](#fig4){ref-type="fig"}).

![***BTN1* overexpression and deletion have opposing effects on Sed5 phosphorylation.** (A) Sed5 is underphosphorylated in cells lacking *BTN1* or *YCK3*. (left) WT cells, WT cells overexpressing *BTN1* from a multicopy plasmid (*BTN1*), and *btn1Δ* cells were grown on glucose-containing medium. In parallel, cells expressing *SED5* under a galactose-inducible promoter (*GAL-SED5*) were grown on galactose-containing medium and were shifted to glucose-containing medium for 16 h (to yield the *sed5Δ* condition). Cells were processed for Western analysis and probed with anti-Sso antibodies to detect Sso1/2 (as a loading control), whereas anti-Sed5 antibodies were used to detect Sed5. NP indicates the lower molecular mass/NP form of Sed5, whereas P indicates the higher molecular mass/P form. The histogram shows quantification (in arbitrary units) of the upper (P) and lower bands (NP) of Sed5 after normalization for Sso loading. (right) Cells expressing *YCK3* under a *GAL* promoter (*GAL-YCK3*) were grown on galactose-containing medium and were shifted to glucose-containing medium for 8 h (to yield the *yck3Δ* condition) or were maintained on galactose-containing medium as a control. In parallel, cells expressing *SED5* under a galactose-inducible promoter (*GAL-SED5*) were grown on galactose-containing medium and were shifted to glucose-containing medium for 16 h (to yield the *sed5Δ* condition). Cells were processed for Western analysis, and both Sed5 and Sso were detected as previously described. Note the presence of only the NP form of Sed5 (NP) in *btn1Δ* cells and in *GAL-YCK3*--expressing cells grown on glucose-containing medium. Also, note lack of Sed5 in *GAL-SED5* cells grown on glucose-containing medium. The histogram shows quantification of the upper (P) and lower bands (NP) after normalization. The data shown are representative of multiple replicates of the experiment (*n* = 4). (B) Yif1 is mislocalized in the absence of Yck3. Yeast lacking *YCK3* (*yck3Δ*) and expressing GFP-Yif1 from a single-copy plasmid were labeled with FM4-64. The top row depicts an endosomal pattern of labeling, whereas the bottom row depicts endosomal and vacuolar labeling. (C) Yif1 is localized to LEs in cells lacking *YCK3*. *yck3Δ* cells expressing GFP-Yif1 and RFP-Vps27 from single-copy plasmids are shown. (D) Kex2 is mislocalized in the absence of Yck3. *yck3Δ* yeast expressing Kex2-GFP from a single-copy plasmid and labeled with FM4-64 are shown. (E) The deletion of *YCK3* enhances Golgi size. WT, *btn1Δ*, and *yck3Δ* cells expressing GFP-Sed5 and RFP-Vps27 from single-copy plasmids are shown. Note that the GFP-Sed5 and RFP-Vps27 signals do not overlap. (F) The double deletion of *BTN1* and *YCK3* does not further enhance Golgi size. *btn1Δyck3Δ* cells expressing GFP-Sed5 from a single-copy plasmid are shown. Bars, 1 µm.](JCB_201102115_RGB_Fig5){#fig5}

![**Yck3 palmitoylation is required for LE--Golgi sorting but can be obviated upon substitution with a TMD.** (A) Palmitoyltransferase activity is required for LE--Golgi retrieval. Yeast lacking five DHHC palmitoyltransferases (*DHHC 5×Δ*) and expressing either *GFP-YIF1* (top) or *KEX2-GFP* (bottom) are shown. Note the localization of Yif1 to LE and vacuole and Kex2 to the vacuole membrane. (B) Yck3 is mislocalized to LEs in cells depleted of palmitoyltransferases. *DHHC 5×Δ* yeast expressing *GFP-YCK3* are shown. (C) Depletion of DHHC palmitoyl transferases reduces Sed5 phosphorylation. WT, *btn1Δ*, and *DHHC 5×Δ* cells were processed for Western analysis with anti-Sed5 and -Sso antibodies, as described in [Fig. 5 A](#fig5){ref-type="fig"}. NP and P indicate the NP and P form of Sed5, respectively. The histogram shows quantification of the Sed5 bands after normalization. The data shown are representative of multiple replicates of the experiment (*n* = 3). (D) Yif1 is mislocalized to LEs in *yck3Δ* cells expressing a Yck3-FYVE fusion protein. WT and *btn1Δ* cells expressing both *YCK3-FYVE* from the *YCK3* locus and *GFP-YIF1* from a single-copy plasmid are shown. (E) Expression of Yck3 fused to a TMD bypasses the Btn1 requirement for Yif1 localization to the Golgi. *btn1Δ* cells and *btn1Δ* cells expressing *YCK3-VAM3* from the *YCK3* locus were transformed with a plasmid expressing GFP-Yif1, labeled with FM4-64, and examined. Note the localization of Yif1 to LEs in *btn1Δ* cells and to smaller puncta (that do not colabel with FM4-64) in cells expressing Yck3-Vam3. (F) Expression of Yck3-Vam3 partially restores Sed phosphorylation. WT, *btn1Δ*, and *btn1Δ* cells expressing *YCK3-VAM3* were processed for Western analysis and Sed5 quantification, as described in [Fig. 5 A](#fig5){ref-type="fig"}. The data shown are representative of multiple replicates of the experiment (*n* = 2). Bars, 1 µm.](JCB_201102115_RGB_Fig6){#fig6}

Loss of Yck3, a palmitoylated protein kinase, leads to defects in LE--Golgi retrieval and Golgi clustering
----------------------------------------------------------------------------------------------------------

Btn1 encodes a multipass membrane-spanning protein that is not a kinase; thus, we determined how it could influence Sed5 phosphorylation and changes in Golgi morphology. Because human CLN3 was proposed, but not independently verified, to encode a palmitoyl protein Δ-9 desaturase of unknown consequence ([@bib37], [@bib38]), we hypothesized that it might act upon palmitoylated proteins that control Sed5 function. Although several palmitoylated proteins function at the Golgi--endosome in yeast, Yck3 and Hrr25 constitute an essential pair of palmitoylated endomembrane-associated kinases ([@bib60]) that could potentially regulate Sed5 phosphorylation. Yck3 localizes to vacuolar membranes and regulates vacuole biogenesis by phosphorylating proteins like Vps41, a homotypic vacuole fusion and vacuole protein sorting complex subunit that localizes to LEs when NP ([@bib32]; [@bib7]), and the Vam3 t-SNARE that mediates vacuolar fusion ([@bib4]). *YCK3* overexpression inhibits the fusion of fragmented vacuoles ([@bib32]), and palmitoylation is required for both function and AP-3--dependent protein sorting to the vacuole ([@bib55]). Recently, Yck3 fused to a FYVE domain was shown to be sufficient to target the kinase to LEs and to locally activate Vps41 ([@bib8]).

To determine whether Yck3 acts downstream of Btn1, we examined whether Yif1 localization is affected by the deletion of *YCK3*. As in *btn1Δ* cells ([Fig. 1 A](#fig1){ref-type="fig"}), Yif1 mislocalized to large puncta and vacuoles in *yck3Δ* cells ([Fig. 5 B](#fig5){ref-type="fig"} \[top and bottom, respectively\] and Table S1). These puncta are probably LEs because Yif1 colocalized with RFP-tagged Vps27 in *yck3Δ* cells ([Fig. 5 C](#fig5){ref-type="fig"}), as previously shown for *btn1Δ* cells ([Fig. 1 B](#fig1){ref-type="fig"}). We also examined whether Kex2 localization is affected by the deletion of *YCK3* and found that Kex2 was mislocalized to large LE-like structures that label with FM4-64 and that are situated adjacent to the vacuole ([Fig. 5 D](#fig5){ref-type="fig"} and Table S2), as seen in *btn1Δ* cells ([Fig. 1 C](#fig1){ref-type="fig"}). As Kex2 mislocalization leads to reduced secretion of active α-mating factor in cells that lack either *BTN1* (Fig. S1 D) or *BTN2* ([@bib27]), we examined whether a similar effect was apparent in *yck3Δ* cells. We found that halo formation induced by the *yck3Δ* cells was also reduced relative to WT cells (Fig. S1 D). Overall, the results suggest that the deletion of *YCK3* phenocopies that of either *BTN1* or *BTN2*. We also examined Yif1 and Kex2 localization in *btn1Δyck3Δ* cells but did not discern significant differences in relation to the single mutants, nor were defects in growth observed (unpublished data). This suggests that *BTN1* and *YCK3* are probably epistatic.

As Yck3 is involved in protein uptake to the vacuole via the AP-3 pathway and not via the clathrin- and endosome-dependent AP-2 route that Yif1 likely takes, we examined whether the AP-3 pathway is affected in *btn1Δ* cells. To do this, we expressed a GFP-tagged Nyv1-Snc1 fusion protein that localizes to the vacuole-limiting membrane in WT cells but is partly mislocalized to the plasma membrane in cells lacking an AP-3 component (e.g., *apl5Δ*). We examined GFP--Nyv1-Snc1 in *btn1Δ* cells and found no mislocalization, unlike in *apl5Δ* or *yck3Δ* cells ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp8}). Thus, the AP-3 pathway appears intact in cells lacking *BTN1*. In addition, we examined localization of GFP-tagged Apl5 expressed from its chromosomal locus in cells lacking *BTN1* but saw no difference with WT cells (Fig. S3 B).

Because the deletion of *BTN1* leads to enhanced Golgi clustering ([Fig. 4](#fig4){ref-type="fig"}), we examined the effect of the deletion of *YCK3* in WT cells and *btn1Δ* cells expressing GFP-Sed5 ([Fig. 5, E and F](#fig5){ref-type="fig"}). In both *yck3Δ* ([Fig. 5 E](#fig5){ref-type="fig"} and [Table S4](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp9}) and *yck3Δbtn1Δ* cells, Sed5 labeled large puncta that did not colabel with RFP-Vps27 or FM4-64 ([Fig. 5 F](#fig5){ref-type="fig"}), indicating that these are not endosomal compartments. Thus, the loss of Btn1 ([Figs. 4](#fig4){ref-type="fig"} and [5 E](#fig5){ref-type="fig"} and Table S4), Yck3 ([Fig. 5 E](#fig5){ref-type="fig"} and Table S4), or both ([Fig. 5 F](#fig5){ref-type="fig"}) results in enlargement of the Golgi.

Btn1 may control Yck3 phosphorylation of Sed5
---------------------------------------------

With the exception of its necessity for AP-3--dependent protein sorting, the deletion of *YCK3* parallels that of *BTN1*. Thus, Yck3 could act downstream of Btn1 and phosphorylate Sed5. To test this hypothesis, we examined Sed5 phosphorylation in cells lacking *YCK3*; however, no significant change in Sed5 phosphorylation was observed therein (unpublished data). Thus, either Yck3 does not phosphorylate Sed5 or, because Yck3 and Hrr25 form an essential pair ([@bib60]), then Hrr25 (or the other Yck kinases, e.g., Yck1 and Yck2) substitutes for Yck3 in the constitutive *yck3Δ* deletion background. To test the latter possibility, we created an inducible form of *YCK3* whose expression from its chromosomal locus is under the control of the *GAL1* promoter. When cells were grown continually in the presence of galactose, both the NP and P forms of Sed5 were observed in Western blots (NP/P ratio = ∼3:1; [Fig. 5 A](#fig5){ref-type="fig"}, right). However, only the NP form of Sed5 was apparent in cells shifted to glucose for 8 h (NP/P ratio = ∼7:1; [Fig. 5 A](#fig5){ref-type="fig"}, top and bottom right). Thus, the turn-off of *YCK3* results in a significant decrease in Sed5 phosphorylation. This suggests that either Yck3 phosphorylates Sed5 directly or that its activation is necessary for Sed5 phosphorylation by another kinase.

One means by which Btn1 might regulate Yck3 is by controlling its localization. Yck3 is mainly found on the vacuolar membrane, although endosome- and plasma membrane--localized Yck3 is functional ([@bib55]; [@bib8]), and the protein likely undergoes palmitoylation early in the secretory pathway (e.g., ER and Golgi) where the DHHC class of palmitoyl transferases is found ([@bib39]). We examined the localization of GFP-tagged Yck3 expressed from its chromosomal locus in cells lacking *BTN1* and found that it labeled the limiting membrane of the vacuole and plasma membrane in both WT and *btn1Δ* cells ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp10}). Thus, Btn1 does not appear to regulate Yck3 localization.

Substitution of the Yck3 lipid anchor with a TMD bypasses the requirement for palmitoylation or Btn1 in LE--Golgi retrieval
---------------------------------------------------------------------------------------------------------------------------

Because Yck3 palmitoylation is essential for its function, we examined whether mutations in the DHHC palmitoyl transferases affect LE--Golgi sorting ([Fig. 6, A and B](#fig6){ref-type="fig"}). The deletion of individual palmitoyltransferase genes, such as *AKR1*, a Golgi protein that palmitoylates Yck kinases ([@bib55]), or *PFA3*, a vacuolar transferase that palmitoylates Vac8 and other substrates ([@bib23], [@bib24]), had no effect on Yif or Kex2 localization (unpublished data). However, we found that both Yif1 and Kex2 were completely mislocalized in cells lacking five of the seven yeast DHHC transferases (i.e., *DHHC 5×Δ* cells; [Fig. 6 A](#fig6){ref-type="fig"} and [Tables S5](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp11} and S2, respectively), which are known to mislocalize Yck3 ([@bib24]). Moreover, we could verify that GFP-Yck3 did not show vacuolar, but rather endosome-like labeling, in these cells ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, selective LE--Golgi protein retrieval is sensitive to changes in DHHC levels, indicating that the palmitoylation of substrates, such as Yck3, is likely to be involved. It is noteworthy to add that the overexpression of *BTN1* did not restore Yif1 or Kex2 Golgi localization in *DHHC 5×Δ* cells (unpublished data), which suggests that Btn1 probably does not enhance Yck3 palmitoylation via the remaining acyltransferases. Lastly, we examined whether Sed5 undergoes phosphorylation in the *DHHC 5×Δ* cells by Western analysis ([Fig. 6 C](#fig6){ref-type="fig"}, top and bottom). We found that levels of the P form of Sed5 were greatly reduced in *btn1Δ* cells (NP/P ratio = 6:1 in *btn1Δ* cells vs. 2:1 in WT cells), as shown in [Fig. 5 A](#fig5){ref-type="fig"}. In the *DHHC 5×Δ* cells, the NP/P ratio remained at ∼6:1 (5.8 ± 0.3; *n* = 2), although the levels of Sed5 protein were similar to those seen in WT cells. Thus, removal of the DHHC transferases inhibits both selective LE--Golgi retrieval and Sed5 phosphorylation.

If Btn1 is a palmitoyl protein desaturase and thus a potential regulator of palmitoylated proteins as suggested for CLN3 ([@bib37], [@bib38]) and LE--Golgi retrieval as suggested here, then substitution of the cysteine-rich palmitoylated domain in Yck3 with either an endosome localization sequence (e.g., FYVE domain) or a TMD could render it functional and restore LE--Golgi retrieval in cells lacking Btn1. Therefore, we deleted *BTN1* in cells expressing Yck3-FYVE ([@bib8]) or Yck3 bearing the Vam3 TMD (which fully supports Vps41 phosphorylation and vacuolar protein sorting; unpublished data) and examined the localization of GFP-Yif1 therein ([Fig. 6, D and E](#fig6){ref-type="fig"}). We found that Yif1 mislocalized to LEs in the *btn1Δ* control and *btn1Δ YCK3-FYVE* cells but not in *btn1Δ YCK3-VAM3* cells ([Fig. 6 \[D and E\]](#fig6){ref-type="fig"} and [Table S5](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp12}). Yif1 localization in the *btn1Δ YCK3-VAM3* cells did not colabel with FM4-64 and appeared Golgi-like. This indicates that addition of a TMD (which confers transport through the secretory pathway) to Yck3 is sufficient to bypass (at least in part) the requirement for Btn1 in selective LE--Golgi sorting. Furthermore, this result implies that Btn1 may affect the lipid anchor of Yck3 in some manner and thus regulate protein function.

We then examined whether Sed5 phosphorylation is restored in *btn1Δ YCK3-VAM3* cells and found that the ratio of NP to P Sed5 was 4.5 ± 0.2:1 (*n* = 2; see representative experiment in [Fig. 6 F](#fig6){ref-type="fig"}, top and bottom). This result was intermediate to that of WT cells, which gave an average ± SD ratio of 2.1 ± 0.1:1 (*n* = 4), and *btn1Δ* cells, which had an average of 7.2 ± 1.7:1 (*n* = 4). Thus, substitution of the Yck3 acyl anchor with a TMD not only appears to restore Yif1 trafficking but may confer the ability of Sed5 to undergo modification.

Sed5 phosphorylation and Golgi morphology are affected in part by the deletion of *BTN2*
----------------------------------------------------------------------------------------

Because the deletion of *BTN1* largely phenocopies that of *BTN2* with respect to protein trafficking (i.e., Yif1 and Kex2 mislocalization and normal Vps10 and CPY localization; [Figs. 1 \[A and C\]](#fig1){ref-type="fig"} and S1 \[A, B, and D\]; [@bib26]), we examined whether the deletion of *BTN2* has parallel effects upon Sed5 phosphorylation and Golgi morphology as that of *BTN1*. First, we examined Sed5 phosphorylation in WT, *btn1Δ*, and *btn2Δ* cells and observed a robust reduction in the P form relative to the NP form (e.g., NP/P ratio = 6.5:1) in cells lacking *BTN2* ([Fig. S5 A](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp13}). This ratio was 2.7:1 in WT control cells and ∼10:1 in the *btn1Δ* cells (in this representative experiment), and no significant effect upon the overall levels of Sed5 protein was observed in the *btn2Δ* cells. Next, we examined Golgi morphology in WT, *btn1Δ*, and *btn2Δ* cells expressing either GFP-Sed5 or GFP-Sed5^317A^. We found that the deletion of *BTN2* had similar effects as the deletion of *BTN1*; namely, an increase in Golgi clustering was observed in *btn2Δ* cells expressing GFP-Sed5 (Fig. S5 B and [Table S6](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp14}). In contrast, *BTN2* overexpression or deletion had little effect on Golgi clusters formed in the presence of GFP-Sed5^317A^ (Fig. S5 C and Table S6). This indicates that Btn2 overproduction does not block Golgi clustering, which is in contrast to *BTN1* overexpression ([Fig. 4 B](#fig4){ref-type="fig"}). Overall, the removal of *BTN2* results in changes in Sed5 phosphorylation and Golgi morphology that are similar to the deletion of *BTN1*. Although this could indicate that Btn1 and Btn2 confer like functions, it is more probable that the removal of *BTN2* results in Btn1 mislocalization to the vacuole (as shown in [Fig. 2 D](#fig2){ref-type="fig"}), hence resulting in a loss of function.

Discussion
==========

We previously demonstrated that *BTN2*, a gene up-regulated in the absence of *BTN1*, encodes a component of a transport complex that retrieves specific proteins back to the Golgi ([@bib26]). We now show that in the absence of *BTN1*, Golgi proteins like Yif1 and TGN-EE proteins like Kex2 fail to retrieve to the Golgi and accumulate in late compartments of the endosomal pathway ([Fig. 1](#fig1){ref-type="fig"} and Tables S1 and S2). This is indicated by the colocalization of Yif1 and Kex2 with FM4-64 and/or Vps27 in cells lacking *BTN1* ([Fig. 1](#fig1){ref-type="fig"}). This phenotype shared between *btn1Δ* and *btn2Δ* cells implies common defects in the sorting of material away from the vacuole to the Golgi. Thus, defects in LE--Golgi protein recycling may contribute to the mechanism underlying Batten Disease/NCL pathogenesis.

Yeast Btn1 and mammalian CLN3 are membrane proteins of unclear function, and, although a wide range of localization patterns and actions have been attributed to them, recent studies from *S. cerevisiae* ([@bib58]), *S. pombe* ([@bib12]), and mammalian cells ([@bib35]) imply that Golgi localization and/or function may be involved. We find that *S. cerevisiae* Btn1 expressed from its chromosomal locus or from single-copy plasmids localizes to Golgi structures ([Fig. 2 A](#fig2){ref-type="fig"}) that colabel with either Yif1 or Sec7 ([Fig. 2 B](#fig2){ref-type="fig"}). Thus, although Btn1 and Btn2 have distinct patterns of localization (i.e., Btn2 localizes to LEs; [@bib26]), both contribute to the same transport process. However, Btn1 probably acts in a different manner than Btn2, which binds to retrieval factors like retromer, endosomal SNAREs, Snx4, and even to Yif1 ([@bib26]). Studies made with cultured mammalian cells or fission yeast suggest that CLN3 and btn1 act in an unknown fashion upon protein export from the Golgi and mislocalize the mannose-6-phosphate receptor or its *S. pombe* equivalent, vps10, respectively, to varying degrees ([@bib35]; [@bib12]). In contrast, Vps10 and CPY trafficking is normal in *btn1Δ* cells (Fig. S1, A and B), as observed for *btn2Δ* cells ([@bib26]; [@bib27]). This suggests that the Vps10--CPY sorting pathway of *S. cerevisiae* differs from that of *S. pombe*. This difference may relate to the finding that both Btn2 and Vps10 colocalize with Vps27 but do not colocalize with each other ([@bib26]), indicating that there may be different LE populations in budding yeast.

Despite differences in Vps10--CPY trafficking, our results suggest that *S. cerevisiae* Btn1 controls protein trafficking within the Golgi. *BTN1* overexpression inhibited Ykt6, an R-SNARE that confers intra-Golgi protein sorting and protein trafficking into and out of the Golgi, from assembling into a canonical 1R--3Q complex with an essential Golgi Q-SNARE, Sed5, and two additional Q-SNAREs implicated in endosome--Golgi trafficking, Vti1 and Tlg1 ([Fig. 3 A](#fig3){ref-type="fig"}). Likewise, the overexpression or deletion of *BTN1* had opposing effects on the ability of Sed5 to assemble into multiple SNARE complexes ([Fig. 3 B](#fig3){ref-type="fig"}) as well as to maintain Golgi morphology ([Fig. 4](#fig4){ref-type="fig"} and Tables S3 and S4). Importantly, Btn1 regulates the phosphorylation state of Sed5, which was shown to control retrograde protein trafficking from the Golgi as well as Golgi morphology ([@bib61]). In the absence of *BTN1,* Sed5 is in an underphosphorylated state ([Figs. 5 A](#fig5){ref-type="fig"}, [6 (C and F)](#fig6){ref-type="fig"}, and S5 A) that mimics the NP form and results in an enhancement of Golgi clustering ([Fig. 4 (A--F)](#fig4){ref-type="fig"} and Table S3) and an increase in SNARE assembly ([Fig. 3 B](#fig3){ref-type="fig"}). In contrast, *BTN1* overexpression mimicked the constitutively P form of Sed5 by dispersing Golgi clusters (e.g., those formed by Sed5^317A^; [Figs. 4 (B and E)](#fig4){ref-type="fig"} and Table S3), reducing SNARE assembly ([Fig. 3 B](#fig3){ref-type="fig"}), and inhibiting the growth of cells bearing mutant SNAREs involved in Golgi trafficking (Fig. S2). Finally, *BTN1* overexpression may even enhance Sed5 modification slightly ([Fig. 5 A](#fig5){ref-type="fig"}). Thus, it appears that Btn1 regulates Sed5 phosphorylation and, therefore, function. Importantly, we noted that the deletion of *BTN2* also had effects on Sed5 phosphorylation and Golgi morphology (Fig. S5); however, these could result from the mislocalization of Btn1 that occurs in *btn2Δ* cells ([Fig. 2 D](#fig2){ref-type="fig"}).

Because Btn1 is not a kinase, it must be indirectly involved in Sed5 phosphorylation. Two pieces of evidence suggested that Yck3 might be involved. First, mammalian CLN3 was suggested to function as a palmitoyl protein desaturase ([@bib37], [@bib38]). Second, Yck3 is a palmitoylated endosome- and vacuole-associated casein kinase involved in protein sorting to the vacuole ([@bib55]; [@bib32]). Moreover, although Yck3 shares essential functions with a paralog, Hrr25 ([@bib60]), and is able to suppress deletions in homologues that function primarily at the plasma membrane (e.g., Yck1 and Yck2; [@bib55]), it also phosphorylates proteins involved in vacuole protein transport, such as Vps41 and Vam3 ([@bib32]; [@bib4]). We examined Sed5 phosphorylation in cells expressing an inducible form of *YCK3* and found that this t-SNARE was underphosphorylated after the turn-off of expression ([Fig. 5 A](#fig5){ref-type="fig"}, right). Thus, Yck3 is a candidate kinase for Sed5 phosphorylation. Moreover, the deletion of *YCK3* resulted in strong defects in LE--Golgi sorting ([Fig. 5, B--D](#fig5){ref-type="fig"}), which parallel those seen in *btn1Δ* and *btn2Δ* cells ([Fig. 1](#fig1){ref-type="fig"} and Tables S1 and S2). This strengthens the idea that Yck3 is involved with Btn1 function, although Sed5 may not be the only substrate involved in the regulation of LE--Golgi sorting. A model for the control of Sed5 and LE--Golgi sorting by Btn1 and Yck3 is shown in [Fig. 7](#fig7){ref-type="fig"}.

![**A model for the control of Sed5 phosphorylation and LE--Golgi transport by Btn1 and Yck3.** Yif1 is in the trans-Golgi in WT cells but delocalizes to the LE in cells lacking either *BTN1* or *YCK3*. Thus, Btn1 and Yck3 mediate Yif1 retrieval. Sed5 is a Golgi SNARE that undergoes a phosphorylation/dephosphorylation cycle important for its localization and function ([@bib61]). Btn1 regulates Yck3 kinase function, resulting in Sed5 phosphorylation either directly by Yck3 (as shown) or indirectly through another kinase (not depicted). Sed5 phosphorylation and dephosphorylation alter SNARE assembly in a manner that regulates retrograde transport, resulting in the retrieval of Yif1 to the Golgi. The phosphatase that dephosphorylates Sed5 is unknown but whose function must be coordinated with Yck3 to control SNARE assembly.](JCB_201102115_GS_Fig7){#fig7}

How Btn1 actually regulates Yck3 function is unclear; however, it might occur via regulation of the lipid anchor moiety. This conjecture is supported by the fact that substitution of the palmitate acceptor region in Yck3 with a TMD allows yeast to bypass the Btn1 requirement in LE--Golgi sorting ([Fig. 6 E](#fig6){ref-type="fig"} and Table S5) and partially restores Sed5 phosphorylation ([Fig. 6 F](#fig6){ref-type="fig"}). Yck3 palmitoylation and membrane anchoring are required for normal vacuolar fusion ([@bib24]) as well as its function in LE--Golgi sorting, the latter being indicated by the fact that Yif1 and Kex2 are missorted in cells lacking five of the DHHC class of palmitoyl transferases ([Fig. 6 A](#fig6){ref-type="fig"} and Tables S2 and S5) and that Sed5 is underphosphorylated therein ([Fig. 6 C](#fig6){ref-type="fig"}). Although we have not proven whether Btn1 (or CLN3) is a palmitoyl protein desaturase, it does show that modulation of the palmitate anchor could play an important role in kinase function in yeast and, potentially, could form the basis for disease onset in postmitotic cells (e.g., neurons) lacking an inherent ability to either control or turn over palmitoylated proteins in a proper fashion. In this regard, it is highly interesting and probably not coincidental that the infantile form of NCL occurs as a result of mutation in a lysosomal palmitoyl thioesterase, although the target substrates for this enzyme have yet to be identified ([@bib57]; [@bib36]; [@bib53]; [@bib18]). If, as in yeast, mammalian CLN3 controls a secretory kinase, screens for regulators of kinase function may identify therapeutic agents of benefit to Batten disease patients.

Materials and methods
=====================

Media, DNA, and genetic manipulations
-------------------------------------

Yeast were grown to midlog phase at 26°C in standard growth media containing either 2% glucose or 3.5% galactose. Synthetic complete and dropout media were prepared as previously described ([@bib20]), whereas rich growth medium (yeast extract peptone dextrose) and an amino acid--enriched synthetic complete medium were prepared according to [@bib51]. Standard methods were used for the introduction of DNA into yeast and the preparation of genomic DNA ([@bib51]). The tagging of genes at their genomic loci with GFP or deletion of genes was performed by homologous recombination using PCR products with flanking regions to the appropriate genomic sequences generated using specific primers to genome-tagging plasmids used as templates ([@bib33]).

Growth tests
------------

For growth tests on plates, yeast were grown to log phase, normalized for optical density (OD~600~), diluted serially (i.e., 10-fold), and plated by drops onto solid medium preincubated at different temperatures.

Halo assays
-----------

Halo assays for measuring the production of biologically active α-factor were performed by spotting *MAT*-α yeast strains onto a lawn of *MAT*a *sst2Δ* indicator yeast, as previously performed ([@bib27]). Assays were performed in triplicate.

Yeast strains and plasmids
--------------------------

The yeast strains used are listed in [Table S7](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp15}. T. Lagrassa (University of Osnabrück, Osnabrück, Germany) provided the the YCK3-VAM3 strain. The plasmids used in this study are listed in [Table S8](http://www.jcb.org/cgi/content/full/jcb.201102115/DC1){#supp16}. To create a plasmid expressing HA-tagged Ykt6-1 (including its 3′ untranslated region \[UTR\], which could be used as a temperature-sensitive tool for use in immunoprecipitation \[IP\] assays), the *ykt6-1* gene (Ykt6 bearing substitutions S35G, L125G, D149G, S182R, and M185T; a gift from D. Banfield, Hong Kong University of Science and Technology, Hong Kong, China) was amplified by PCR using the isolated balancer plasmid recovered from the SARY 166 strain as a template and primers encoding SalI and SacI sites for amplification at the 5′ and 3′ ends, respectively. The SalI--SacI fragment was inserted in-frame and downstream to the myc epitope encoded in vector pRS313 (*CEN* and *URA3*). To create a yeast expression plasmid for *CLN3*, the human *CLN3* gene was amplified by PCR using cDNA derived from HeLa cells as a template and primers encoding SalI and SacI sites for amplification at the 5′ and 3′ ends, respectively. The SalI--SacI fragment was inserted in-frame and downstream to the HA epitope encoded by vector pAD54 (2μ and *LEU2*). A construct for the integration of *GFP*-tagged *BTN1* at its genomic locus was created by subcloning an SalI and BglII fragment bearing *GFP*-*BTN1-3′UTR* from plasmid pUG46-GFP-BTN1(+3′ UTR) into plasmid pFA6a--*nat*MX4, which encodes a PCR amplification module for integration at target genes using selection for resistance to nourseothricin via the SalI and BglII sites. After verification by sequencing, an integration cassette containing *GFP-BTN1-3′UTR-natMX-BTN1* was amplified using a 60-bp forward chimeric oligonucleotide corresponding to the 5′ UTR of *BTN1* and *GFP* (which follows directly downstream) and a 60-bp reverse chimeric oligonucleotide corresponding to the pFA6a-nat-MX4 plasmid (after the *nat* gene sequence) and a region of the 3′ UTR of *BTN1* beginning 210 bp after the stop codon. Fragments obtained by PCR amplification were used to transform WT yeast and were selected for medium containing clonNAT (nourseothricin; CAS no. 96736-11-7; WERNER BioAgents). Integration at the *BTN1* locus was verified by PCR.

Microscopy
----------

GFP and RFP fluorescence in strains expressing the appropriate GFP- and RFP-tagged fusion proteins/FM4-64 fluorescence, respectively, was visualized by confocal microscopy. Unless mentioned, cells were grown to midlog phase at 26°C in synthetic selective medium before visualization. For vacuolar staining, cells were pulsed with 5.4 µM FM4-64 (Invitrogen) for 30 min in the dark at 26°C. After the pulse, a chase of 20 min in the same medium lacking FM4-64 was performed. In the figures, merge indicates either merger of the GFP and FM4-64 panels or GFP and RFP panels where appropriate. Light indicates the differential interference contrast (DIC) panel. All bars equal 1 µm. Images were captured with a confocal imaging system (LSM 710; Carl Zeiss) mounted on an inverted microscope (AxioObserver; Carl Zeiss) using a Plan Apochromat 63×/1.40 N.A. objective. Image acquisition was accomplished at 26°C using the detection system and accompanying software provided by the manufacturer. Photoshop (Adobe) was used to assemble and size the images for figure preparation.

IP and Western analysis
-----------------------

Cell lysates for use in IP experiments and immunoblots were prepared using glass beads to break intact cells. Cells were grown to midlog phase at 26°C before harvesting, washed with TE (10 mM Tris-Hcl, pH 7.5, and 1 mM EDTA), and resuspended in 250--300 µl of lysis buffer consisting of TE containing 1% NP-40 (volume/volume), 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor, 10 µg/ml pepstatin, and 100 µM PMSF. For the detection of P Sed5 in Western blots, the lysis buffer was supplemented with the following phosphatase inhibitors: 10 mM NaF, 20 mM NaPPi, 25 mM β-glycerophosphate, and 0.5 mM sodium vanadate. For IP experiments, 15 OD~600~ units of cells were used for each pull-down. Cell extracts were prepared by adding an equal volume of washed glass beads (e.g., 0.25 ml) to the cells followed by prolonged shaking at 2,200 rpm in a Vibrax shaker (IKA Laboratories Ltd.) at 4°C for 45 min. Extracts were clarified by centrifugation at 12,000 *g* for 10 min to yield total cell lysates (TCLs). Protein concentration was determined using the Pierce MicroBCA protein assay kit (Thermo Fisher Scientific). For each IP reaction, 0.5 mg of TCL was diluted with ice-cold IP buffer (1% NP-40 in TE) to a final volume of 0.5 ml and was incubated with the appropriate IP antibody (see below). IP was performed at 4°C with constant rotation for 16 h, and precipitation of the complexes was performed by adding a 30-µl bed volume of protein G--agarose (Santa Cruz Biotechnology, Inc.) prewashed in IP buffer to the IP mixture. After 2 h of incubation with constant rotation, the complexes were spun down and washed three times with ice-cold IP wash buffer (TE containing 1% NP-40 and 150 mM NaCl). Precipitated proteins were resuspended in 30 µl SDS-PAGE sample buffer and boiled (3 min) before electrophoresis on 10 and 12.5% polyacrylamide gels (i.e., low molecular mass proteins \<60 kD were resolved on 12.5% gels, whereas high molecular mass proteins \>60 kD were resolved in parallel on 10% gels). Where relevant, samples of TCLs (e.g., 30 µg of protein per lane) were electrophoresed in parallel to the IP samples. For immunoblotting, gels were electroblotted onto pure nitrocellulose blotting membranes (BioTrace; Pall Corporation). Blots were blocked with 5% nonfat milk in TBS (PBS solution containing 0.05% Tween 20) and then probed with the appropriate antibody in TBS containing 5% BSA and 3 mM NaN~3~. Protein expression was detected by an ECL detection kit (GE Healthcare).

Affinity-purified IP antibodies included monoclonal anti-myc (9E10, 3 µl per IP; Santa Cruz Biotechnology, Inc.) and anti-HA antibodies (16B12, 2.5 µl per IP; Covance). Antibodies for protein detection in Western blots or on nitrocellulose filters included polyclonal antibodies against Bet1 (diluted 1:1,000; provided by C. Barlowe, Dartmouth College, Hanover, NH); CPY (a gift from S. Emr, University of California, San Diego, La Jolla, CA); Gos1, Sft1, and Ykt6 (diluted 1:1,000; gifts from D. Banfield); Sed5 (diluted 1:3,000; a gift from H. Pelham, Medical Research Council, Cambridge, England, UK); Snc1 (diluted 1:500; [@bib48]); Sso1/2 (diluted 1:1,000; a gift from S. Keranen, Technical Research Centre of Finland, Espoo, Finland); Tlg1 (diluted 1:3,000; a gift from H. Pelham); Tlg2 (diluted 1:750; a gift from H. Abeliovich, Hebrew University of Jerusalem, Rehovot, Israel); Vti1 (diluted 1:1,000; a gift from G. Fischer von Mollard, University of Göttingen, Göttingen, Germany); and monoclonal antibodies to the HA and myc epitopes (diluted 1:1,000).

To distinguish between the higher and lower molecular mass forms of Sed5 (i.e., upper and lower bands), TCL samples were subjected to SDS-PAGE on 11.5% acrylamide gels. Quantification of the upper (i.e., P) and lower (i.e., NP) bands of Sed5 in Western blots by density measurement was performed using ImageJ software (National Institutes of Health). Molecular mass markers are listed in kilodaltons for all Western blots.

Online supplemental material
----------------------------

Fig. S1 demonstrates that the deletion or overexpression of *BTN1* does not alter localization of a wide variety of endosome-trafficked proteins. Fig. S2 shows that the deletion and overexpression of *BTN1* have opposing effects on the growth of temperature-sensitive mutants of Golgi SNAREs. Fig. S3 shows that the deletion of *BTN1* does not affect AP3-mediated protein sorting or localization of an AP-3 component. Fig. S4 shows that Yck3 is not mislocalized in *btn1Δ* cells, although *YCK3* overexpression inhibits the growth of Golgi SNARE mutants. Fig. S5 shows that the deletion of *BTN2* also affects Sed5 phosphorylation and Golgi morphology. Table S1 provides statistics for the localization of GFP-Yif1 in *btn1Δ* and *yck3Δ* cells. Table S2 provides statistics for the localization of Kex2-GFP in *btn1Δ*, *yck3Δ*, and *DHHC* 5×*Δ* cells. Table S3 provides statistics for the localization of GFP-Sed5 in WT cells lacking or overexpressing *BTN1*. Table S4 provides statistics for the localization of GFP-Sed5 in *yck3Δ* cells. Table S5 provides statistics for the localization of GFP-Yif1 in cells expressing mutant Yck3 proteins or lacking DHHC palmitoyl transferases. Table S6 provides statistics for the localization of GFP-Sed5 in cells lacking or overexpressing *BTN2*. Table S7 includes the yeast strains used in this study, and Table S8 includes the plasmids used for this study. Finally, Table S9 provides a glossary describing the genes used in this study. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201102115/DC1>.
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